NRx Pharmaceuticals, Inc. announced submission an Investigational New Drug application to the U.S. Food and Drug Administration for the use of NRX-101 to treat Chronic Pain.
NRx Pharmaceuticals, Inc. announced submission an Investigational New Drug application to the U.S. Food and Drug Administration for the use of NRX-101 to treat Chronic Pain.